Sitemap
- Products
- Bioporto Diagnostics
- Antibodyshop
- Alphabetical list
- Cell biology
- Coagulation
- Collectins and related products
- Complement
- C1-inhibitor (C1INH)
- C1s (human, pro- and activated enzyme)
- Complement component C2 (human)
- Complement component C3
- Complement component C4 (human)
- Complement component C5 (human)
- Complement component C9 (human)
- Complement factor B
- Complement factor D (human)
- Complement factor H
- Complement factor I (human)
- Mannan-binding lectin
- Properdin
- Cytokines and hormones
- Adrenomedullin (human)
- Alfa-CGRP
- Chorionic gonadotrophin (human, hCG)
- Estrogens
- Exendin-4
- Gastric inhibitory polypeptide (GIP)
- Glucagon-like peptide-1 (GLP-1)
- Glucagon-like peptide-2 (human, hGLP-2)
- Leptin
- Neuropeptide Y
- Pancreatic Polypeptide (human, PP)
- Peptide histidine-methionine (PHM)
- Peptide YY (human, PYY)
- Tumor necrosis factor alpha (TNF alpha)
- Vasoactive intestinal peptide (VIP)
- Enzymes
- Marker molecules
- Acetylcholinesterase
- Alpha-fetoprotein (human)
- Amyloid beta-peptide
- Butyrylcholinesterase (human)
- NGAL (human, neutrophil gelatinase-associated lipocalin)
- NGAL (monkey, neutrophil gelatinase-associated lipocalin)
- NGAL (rat, neutrophil gelatinase-associated lipocalin)
- Placental protein 14 (human, glycodelin A)
- Pregnancy associated plasma protein A (PAPP-A)
- Procollagen
- Microbiology
- Miscellaneous
- Oncology
- Other blood proteins
- Sera and Antigens
- How to buy
- All other countries
- Australia
- Austria
- Belgium
- Brazil
- Canada
- China
- Czech Republic
- Denmark
- Egypt
- Finland
- France
- Germany
- Greece
- India
- Iran
- Ireland
- Italy
- Japan
- Jordan
- Korea
- Kuwait
- Lebanon
- Libya
- Luxembourg
- Netherlands
- Norway
- Portugal
- Romania
- Saudi Arabia (K.S.A.)
- Slovakia
- South Africa
- Spain
- Sweden
- Switzerland
- Taiwan
- Turkey
- U.A.E.
- United Kingdom
- United States
- Investors
- Announcements
- 2008
- 2007
- 29: Settlement between SSI and BioPorto
- 28: Trading report
- 27: Interim financial statement
- 26: Devl. of extraordinary general meeting
- 25: Trading report
- 24: Stock capital and votes
- 23: Extraordinary general meeting
- 22: Articles of association
- 21: Exercise of warrants
- 20: Prospectus
- 19: Prospectus Announcement
- 18: Stock capital and votes
- 17: BioPorto continues negotiations
- 16: Trading report
- 15: Devl. of annual general meeting
- 14: Notification from major shareholder
- 13: BioPorto to issue new shares in a directs placement
- 12: Annual general meeting
- 11: Trading report
- 10: Trading report
- 09: Annual report
- 08: Status: NGAL patent
- 07: Devl. of extraordinary general meeting
- 06: Extraordinary general meeting
- 05: Financial calendar 2007 (corrected)
- 04: Fondsrådets afgørelser mv.
- 03: Akkvistition af Merlin
- 02: Alternativ indregning af cellelinier
- 01: Financial Calendar 2007
- 2006
- 22: Status: Akkvisitioner og fokusområder
- 21: Kontant rettet emission – T.DKK 20.000
- 20: NGAL hurtig analyse lancering
- 19: Fondsrådets 2. afgørelse, fuld længde
- 18: Fondsrådets 2. afgørelse
- 17: Korrigerende info til delårsrapport 2006
- 16: Korrigerende info til årsrapport 2004 og 2005
- 15: Fondsrådets afgørelse
- 14: Halvårsrapport 2006
- 13: Fondsrådets regnskabskontrol
- 12: Interface Biotech forhandling
- 11: Akkvisition Merlin Diagnostika
- 10: Warrantsprogram og kapitalforhøjelser
- 09: Insideres handler
- 08: Forløb af ordinær generalforsamling
- 07: Indkaldelse til ordinær generalforsamling
- 06: Årsrapport 2005
- 05: Insideres handler
- 04: Akkvisition af Merlin
- 03: Insideres handel
- 02: Finanskalender 2006
- 01: Akkvisitionsstatus
- 2005
- 2004
- Share information
- Newsletter
- Presentations
- Key Figures
- Financial calendar
- Corporate governance
- News mail
- Contact investor relations
- Announcements
- About us
- Mission and Vision
- Board of Directors
- Management
- Strategy
- Distribution and licensing
- Events
- The Biomarker World Congress 2008, 19 - 21 May, Philadelphia, USA
- 5th International Conference on Innate Immunity, June 21-26, 2008, Chania, Crete, Greece
- The 23rd International Lectin Conference, INTERLEC-23, 11-16 July, 2008 Universities of Edinburg and Stirling, Scotland
- American Association for Clinical Chemistry's 2008 Annual Meeting (AACC), 27-31 July 2008, Washington DC, USA
- 22nd International Complement Workshop, 28 September – 2 October 2008
- Renal Week 2008, 41st Annual Meeting and Scientific Exposition, November 4 - 9, 2008
- 40th World Forum for Medicine, MEDICA, November 19-22, 2008
- 28th International Symposium on Intensive Care and Emergency Medicine, 18-21 March, 2008 Brussels, Belgium
- Arab Health Congress, 28 - 31 Jan 2008, International Exhibition Center, Dubai, UAE
- 47th Society of Toxicology Annual Meeting and ToxExpo, 16-20 March, 2008, Seattle, Washington
- Career
